sulfobromophthalein has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Sulfobromophthalein: A phenolphthalein that is used as a diagnostic aid in hepatic function determination.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Serdiuk, VA | 1 |
Novopashennaia, VV | 1 |
Grodzki, M | 1 |
Mazurkiewicz-Rozynska, E | 1 |
Czyzyk, A | 1 |
2 other studies available for sulfobromophthalein and Diabetes Mellitus, Type 1
Article | Year |
---|---|
[Liver function in diabetics with secondary sulfanilamide resistance (based on the data from dynamic hepatobiliary scintigraphy)].
Topics: Biliary Tract; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Resistanc | 1991 |
Diabetic cholecystopathy.
Topics: Adolescent; Adult; Bile; Cholecystography; Diabetes Complications; Diabetes Mellitus, Type 1; Female | 1968 |